血液透析血管接取装置市场：市场规模（按细分市场）、份额、监管、报销、程序、预测（~2033）

当肾臟停止运作时，水会滞留在体内，有害废物会累积。末期肾病 (ESRD) 患者需要治疗以替代衰竭的肾臟功能。

慢性肾臟病（CKD）是一种肾功能在一段时间内下降的疾病。若肾丝球滤过率持续低于60 毫升每分钟超过3 个月，或尿液白蛋白/肌酸酐比值超过每1 克(g) 肌酸酐(30 mg/g) 含白蛋白30 毫克(mg)，则成为CKD 。

急性肾损伤是肾功能突然、暂时、有时甚至致命的下降。

本报告深入探讨了全球血液透析血管通路装置市场，包括竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响以及区域和国家趋势。

目录

目前市售的血液透析血管通路装置及竞争状况

• 洞察关键产业趋势
• 血液透析血管通路装置的市场总收入及按细分市场划分的竞争格局
• 有关单位、平均售价和市场价值的详细数据

全球、区域和国家见解

• 血液透析血管通路器械市场SWOT分析
• 血液透析血管接取设备市场的竞争动态洞察与趋势
• 按国家/地区划分的医疗保健系统概览
• 各国报销政策
• 各国医疗技术法规现状

Abstract

Vascular Access Devices for Hemodialysis Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Nephrology and Urology Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Vascular Access Devices for Hemodialysis market for the year 2020 and beyond.

End-Stage Renal Disease (ESRD):

Total and permanent kidney failure. When the kidneys fail, the body retains fluid. Harmful wastes build up. A person with ESRD needs treatment to replace the work of the failed kidneys.

Chronic Kidney Disease (CKD):

Any condition that causes reduced kidney function over a period of time. CKD is present when a patient's glomerular filtration rate remains below 60 milliliters per minute for more than 3 months or when a patient's urine albumin-to-creatinine ratio is over 30 milligrams (mg) of albumin for each gram (g) of creatinine (30 mg/g).

Acute Kidney Injury:

Sudden, temporary, and sometimes fatal loss of kidney function.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Vascular Access Devices for Hemodialysis and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Vascular Access Devices for Hemodialysis market revenue by segment and market outlooks from

2015- 2033.

• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Vascular Access Devices for Hemodialysis.
• Competitive dynamics insights and trends provided for Vascular Access Devices for Hemodialysis market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Fresenius SE & Co KGaA, Becton Dickinson and Co, Baxter International Inc, Medtronic Plc, B. Braun Melsungen AG, W. L. Gore & Associates Inc, NIPRO Corp, and others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Vascular Access Devices for Hemodialysis market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Vascular Access Devices for Hemodialysis market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Vascular Access Devices for Hemodialysis market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Vascular Access Devices for Hemodialysis market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Vascular Access Devices for Hemodialysis market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable